Ingemar Lagerlöf
4PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jan 25, 2022
Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy.Ingemar Lagerlöf, Helena Fohlin, Gunilla Enblad
|Aug 26, 2021
Idelalisib in relapsed/refractory diffuse large B-cell lymphoma: results from a Nordic Lymphoma Group phase II trial.Karin Fjordén, Sara Ekberg, Nevzeta Kuric
|Feb 05, 2020
Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real-world patients.Lasse H Jakobsen, Fredrik Ellin, Knut B Smeland
|Oct 16, 2019
No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy.Ingemar Lagerlöf, Harald Holte, Ingrid Glimelius
Pageof 1
Frequent Collaborators
2 joint publications
Harald Holte
2 joint publications
Ingrid Glimelius
1 joint publications
Lasse H Jakobsen
1 joint publications
Gita Thanarajasingam
1 joint publications
Karin Fjordén
1 joint publications
Sara Ekberg
1 joint publications
Helena Fohlin
1 joint publications
Gunilla Enblad
1 joint publications
Christina Goldkuhl
1 joint publications
Marzia Palma
